⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NBIX News
Neurocrine Biosciences Inc
Motive revela el futuro de las operaciones físicas en Vision 26: Una nueva era de hardware integrado e innovaciones de IA
businesswire.com
HAL
KMT
NBIX
Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA® (valbenazine) Capsules
prnewswire.com
NBIX
Form 8-K
sec.gov
NBIX
Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics
prnewswire.com
NBIX
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer
globenewswire.com
LEGN
NBIX
4basebio Announces Appointment of Chief Financial Officer and Board Changes
globenewswire.com
NBIX
MREO
Neurocrine Biosciences Announces Publication of Expert Recommendations for Glucocorticoid Dose Reduction after Initiating CRENESSITY® (crinecerfont) for the Treatment of Classic Congenital Adrenal Hyperplasia
prnewswire.com
NBIX
Nona Biosciences Evolves Brand to Reflect Next Phase of Growth in Biotherapeutic Innovation
prnewswire.com
NBIX
Form 8-K
sec.gov
NBIX
Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
prnewswire.com
NBIX